Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Revance Therapeutics (RVNC)
NASDAQ:RVNC
Revance Therapeutics (RVNC) Ownership - Who Owns Revance Therapeutics?
578 Followers
Revance Therapeutics (RVNC) Ownership Overview
12.85% Insiders
36.66% Mutual Funds
11.89% Other Institutional Investors
38.61% Public Companies and
Individual Investors
The ownership structure of Revance Therapeutics (RVNC) stock is a mix of institutional, retail and individual investors. Approximately 48.54% of the company’s stock is owned by Institutional Investors, 12.85% is owned by Insiders and 38.61% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 17, 2024 | Erica Jordan Chief Commercial Officer | xxxxxxxxxxxxx | $9090 |
| Mar 19, 2024 | xxxxxxxxxxxxx | $67436 | |
| Mar 19, 2024 | Dwight Moxie Clo & Gc | xxxxxxxxxxxxx | $58276 |
| Mar 19, 2024 | Dustin S Sjuts President | xxxxxxxxxxxxx | $62149 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $97937 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $1230000 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $2952000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,384,192 | Institution | 7.07% | 26,841,538 | |
| 6,334,383 | Institution | 6.06% | 23,025,482 | |
| 5,350,417 | Institution | 5.12% | 19,448,766 | |
| 5,301,411 | Institution | 5.08% | 19,270,629 | |
| 4,308,725 | Institution | 4.13% | 15,662,215 | |
| 3,096,650 | Insider | 2.96% | 11,256,323 | |
| 3,096,650 | Insider | 2.96% | 11,256,323 | |
| 3,096,650 | Insider | 2.96% | 11,256,323 | |
| 3,030,752 | Institution | 2.90% | 11,016,784 | |
| 1,845,529 | Institution | 1.77% | 6,708,498 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,384,192 | Institution | 7.07% | 26,841,538 | |
| 6,334,383 | Institution | 6.06% | 23,025,482 | |
| 4,308,725 | Institution | 4.13% | 15,662,215 | |
| 3,030,752 | Institution | 2.90% | 11,016,784 | |
| 1,845,529 | Institution | 1.77% | 6,708,498 | |
| 1,520,609 | Institution | 1.46% | 5,527,414 | |
| 955,389 | Institution | 0.91% | 3,472,839 | |
| 936,581 | Institution | 0.90% | 3,404,472 | |
| 918,496 | Institution | 0.88% | 3,338,733 | |
| 905,194 | Institution | 0.87% | 3,290,380 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,750,828 | Institution | 2.63% | 9,999,260 | |
| 3,094,072 | Institution | 2.96% | 7,951,765 | |
| 1,429,562 | Institution | 1.37% | 3,673,974 | |
| 926,262 | Institution | 0.89% | 3,366,962 | |
| 707,242 | Institution | 0.68% | 2,570,825 | |
| 495,114 | Institution | 0.47% | 1,807,166 | |
| 276,914 | Institution | 0.27% | 1,006,582 | |
| 387,601 | Institution | 0.37% | 996,135 | |
| 333,978 | Institution | 0.32% | 858,323 | |
| 233,965 | Institution | 0.22% | 850,463 |
FAQ
Who Owns Revance Therapeutics (RVNC)?
According to the latest TipRanks data, approximately 11.89% of the company's stock is held by institutional investors, 12.85% is held by insiders, and 38.61% is held by retail investors.
What percentage of Revance Therapeutics (RVNC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.89% of Revance Therapeutics (RVNC) stock is held by institutional investors.
What percentage of Revance Therapeutics (RVNC) stock is held by retail investors?
According to the latest TipRanks data, approximately 38.61% of Revance Therapeutics (RVNC) stock is held by retail investors.
Who owns the most shares of Revance Therapeutics (RVNC)?
SMALLCAP World Fund Inc owns the most shares of Revance Therapeutics (RVNC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.